company background image
PNVL3 logo

Dimed Distribuidora de Medicamentos BOVESPA:PNVL3 Stock Report

Last Price

R$8.71

Market Cap

R$1.3b

7D

-10.6%

1Y

-30.5%

Updated

18 Dec, 2024

Data

Company Financials +

Dimed S.A. Distribuidora de Medicamentos

BOVESPA:PNVL3 Stock Report

Market Cap: R$1.3b

PNVL3 Stock Overview

Sells medicines, perfumeries, personal care and beauty products, cosmetics, and dermo-cosmetics in Brazil. More details

PNVL3 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance5/6
Financial Health5/6
Dividends4/6

My Notes

Capture your thoughts, links and company narrative

Dimed S.A. Distribuidora de Medicamentos Competitors

Price History & Performance

Summary of share price highs, lows and changes for Dimed Distribuidora de Medicamentos
Historical stock prices
Current Share PriceR$8.71
52 Week HighR$13.36
52 Week LowR$8.64
Beta0.37
1 Month Change-10.21%
3 Month Change-14.52%
1 Year Change-30.54%
3 Year Change-32.53%
5 Year Change-55.64%
Change since IPO171,255.50%

Recent News & Updates

Dimed S.A. Distribuidora de Medicamentos Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Nov 17
Dimed S.A. Distribuidora de Medicamentos Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Recent updates

Dimed S.A. Distribuidora de Medicamentos Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Nov 17
Dimed S.A. Distribuidora de Medicamentos Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Investors Could Be Concerned With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Returns On Capital

Nov 04
Investors Could Be Concerned With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Returns On Capital

These 4 Measures Indicate That Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Using Debt Extensively

Jul 12
These 4 Measures Indicate That Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Using Debt Extensively

Investors Shouldn't Be Too Comfortable With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Robust Earnings

May 27
Investors Shouldn't Be Too Comfortable With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Robust Earnings

Be Wary Of Dimed Distribuidora de Medicamentos (BVMF:PNVL3) And Its Returns On Capital

Apr 15
Be Wary Of Dimed Distribuidora de Medicamentos (BVMF:PNVL3) And Its Returns On Capital

Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Seems To Use Debt Quite Sensibly

Mar 25
Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Seems To Use Debt Quite Sensibly

The Returns On Capital At Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Don't Inspire Confidence

Jan 06
The Returns On Capital At Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Don't Inspire Confidence

Dimed S.A. Distribuidora de Medicamentos' (BVMF:PNVL3) Stock Retreats 26% But Earnings Haven't Escaped The Attention Of Investors

Oct 23
Dimed S.A. Distribuidora de Medicamentos' (BVMF:PNVL3) Stock Retreats 26% But Earnings Haven't Escaped The Attention Of Investors

Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Reinvesting At Lower Rates Of Return

Aug 15
Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Reinvesting At Lower Rates Of Return

Shareholder Returns

PNVL3BR Consumer RetailingBR Market
7D-10.6%-13.1%-7.2%
1Y-30.5%-33.7%-11.5%

Return vs Industry: PNVL3 matched the BR Consumer Retailing industry which returned -29.6% over the past year.

Return vs Market: PNVL3 underperformed the BR Market which returned -9.2% over the past year.

Price Volatility

Is PNVL3's price volatile compared to industry and market?
PNVL3 volatility
PNVL3 Average Weekly Movement3.3%
Consumer Retailing Industry Average Movement7.1%
Market Average Movement5.0%
10% most volatile stocks in BR Market9.2%
10% least volatile stocks in BR Market2.7%

Stable Share Price: PNVL3 has not had significant price volatility in the past 3 months compared to the BR market.

Volatility Over Time: PNVL3's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
192010,145Julio Mottin Netowww.dimed.com.br

Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal care and beauty products, cosmetics, and dermo-cosmetics in Brazil. The company operates in Retail and Wholesale segments. It offers its products through distribution centers in the states of Rio Grande do Sul, Paraná, and Espírito Santo.

Dimed S.A. Distribuidora de Medicamentos Fundamentals Summary

How do Dimed Distribuidora de Medicamentos's earnings and revenue compare to its market cap?
PNVL3 fundamental statistics
Market capR$1.34b
Earnings (TTM)R$103.55m
Revenue (TTM)R$4.82b

12.6x

P/E Ratio

0.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PNVL3 income statement (TTM)
RevenueR$4.82b
Cost of RevenueR$3.29b
Gross ProfitR$1.53b
Other ExpensesR$1.43b
EarningsR$103.55m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.69
Gross Margin31.75%
Net Profit Margin2.15%
Debt/Equity Ratio40.8%

How did PNVL3 perform over the long term?

See historical performance and comparison

Dividends

2.9%

Current Dividend Yield

17%

Payout Ratio

Does PNVL3 pay a reliable dividends?

See PNVL3 dividend history and benchmarks
When do you need to buy PNVL3 by to receive an upcoming dividend?
Dimed Distribuidora de Medicamentos dividend dates
Ex Dividend DateApr 08 2024
Dividend Pay DateMar 31 2025
Days until Ex dividend255 days
Days until Dividend pay date102 days

Does PNVL3 pay a reliable dividends?

See PNVL3 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 01:42
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dimed S.A. Distribuidora de Medicamentos is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Marcio OsakoBradesco S.A. Corretora de Títulos e Valores Mobiliários
Francisco NavarreteBradesco S.A. Corretora de Títulos e Valores Mobiliários
Frederico MendesBradesco S.A. Corretora de Títulos e Valores Mobiliários